Your trusted destination for CME, CPD & Medical Education across the Middle East.
University of Milano & European Institute of Oncology, Italy
Prof. Dr. Giuseppe Curigliano is an internationally renowned medical oncologist, clinical researcher, and academic leader who has dedicated his career to advancing early-phase drug development, translational breast cancer research, and precision oncology. He earned his medical degree and specialized doctorate (PhD) in medical oncology from the University of Milan, where he built a distinguished foundation in clinical pharmacology, cancer therapeutics, and molecular pathology. His clinical training and research pursuits have consistently focused on bridging bench-side scientific discoveries with innovative clinical trials designed to target tumor vulnerabilities while minimizing systemic toxicity.
Holding prominent academic and clinical directorships, Dr. Curigliano serves as Professor of Medical Oncology at the University of Milan and heads the Early Drug Development Division at the prestigious European Institute of Oncology (IEO) in Milan, Italy. He is widely recognized as a global authority in breast cancer therapy, particularly in the clinical evaluation of antibody-drug conjugates (ADCs), immunotherapy combinations, and molecularly targeted treatments for treatment-resistant malignancies. Furthermore, he maintains active leadership roles within major international societies,serving as Scientific Chair for the European Society for Medical Oncology (ESMO) and contributing extensively to global clinical practice guidelines.
Beyond his institutional leadership and clinical practice, Dr. Curigliano is a prolific author and principal investigator,having published over 400 peer-reviewed articles in high-impact journals such as the New England Journal of Medicine,The Lancet, and the Journal of Clinical Oncology.

INDEX Conferences and Exhibitions Organization L.L.C
INDEX Conferences and Exhibitions Organization L.L.C

LUMINA
LUMINA